Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bumi Citra Permai Tbk (BCIP) vs Diagnos Laboratorium Utama Tbk. (DGNS) Price & Performance

Bumi Citra Permai TbkTrade
Diagnos Laboratorium Utama Tbk.Trade

Price performance (Past 24H)

Key statistics

Bumi Citra Permai Tbk vs Diagnos Laboratorium Utama Tbk. — how do they compare? Bumi Citra Permai Tbk trades at Rp62 (market cap 90.08B, 3.65M 24h volume), while Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 3.5× Bumi Citra Permai Tbk's market cap, and Bumi Citra Permai Tbk is more actively traded (3.65M versus 41.7K). Which is the better fit depends on your goals.

BCIPDGNS
Market Cap
90.08B316.25B
Volume
3.65M41.7K
Lot
36.48K417
Turnover
228.65M9.66M
Average Price
62.67231.65
Value
228.65M9.66M
Indicative Equilibrium Price
62230
Indicative Equilibrium Volume
1.79K2.4K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BCIP
View details
DGNS
View details

About Bumi Citra Permai Tbk

PT Bumi Citra Permai Tbk (the company) was established on 3 May 2000 based on Notaries Deed No. 2 and the deed of establishment was approved by the the Ministry of Justice dated Sep 7, 2000. The Company’s articles of association has been amended several times, most recently by notarial deed No. 9 of Robert Purba, S.H., dated 6 May, 2009, concerning among others, public offering and issue warrant.

Read more on BCIP

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS